Literature DB >> 32047371

Working With a Patient With Bipolar I Disorder Who Is Experiencing Depression.

Jeffrey J Rakofsky1.   

Abstract

Entities:  

Keywords:  Administration & management; Ethics

Year:  2019        PMID： 32047371      PMCID： PMC6999213          DOI： 10.1176/appi.focus.20190012

Source DB:  PubMed          Journal:  Focus (Am Psychiatr Publ)        ISSN： 1541-4094


× No keyword cloud information.
  14 in total

Review 1.  Lithium: still a major option in the management of bipolar disorder.

Authors:  Rasmus W Licht
Journal:  CNS Neurosci Ther       Date:  2011-06-23       Impact factor: 5.243

2.  Lurasidone as adjunctive therapy with lithium or valproate for the treatment of bipolar I depression: a randomized, double-blind, placebo-controlled study.

Authors:  Antony Loebel; Josephine Cucchiaro; Robert Silva; Hans Kroger; Kaushik Sarma; Jane Xu; Joseph R Calabrese
Journal:  Am J Psychiatry       Date:  2014-02       Impact factor: 18.112

3.  Efficacy and safety of fluoxetine in treating bipolar II major depressive episode.

Authors:  J D Amsterdam; F Garcia-España; J Fawcett; F M Quitkin; F W Reimherr; J F Rosenbaum; E Schweizer; C Beasley
Journal:  J Clin Psychopharmacol       Date:  1998-12       Impact factor: 3.153

Review 4.  Suicide attempts in bipolar I and bipolar II disorder: a review and meta-analysis of the evidence.

Authors:  Danielle M Novick; Holly A Swartz; Ellen Frank
Journal:  Bipolar Disord       Date:  2010-02       Impact factor: 6.744

5.  Impact of antidepressant discontinuation after acute bipolar depression remission on rates of depressive relapse at 1-year follow-up.

Authors:  Lori Altshuler; Trisha Suppes; David Black; Willem A Nolen; Paul E Keck; Mark A Frye; Susan McElroy; Ralph Kupka; Heinz Grunze; Jörg Walden; Gabrielle Leverich; Kirk Denicoff; David Luckenbaugh; Robert Post
Journal:  Am J Psychiatry       Date:  2003-07       Impact factor: 18.112

6.  Treatment nonadherence and neurocognitive impairment in bipolar disorder.

Authors:  Anabel Martinez-Aran; Jan Scott; Francesc Colom; Carla Torrent; Rafael Tabares-Seisdedos; Claire Daban; Marion Leboyer; Chantal Henry; Guy M Goodwin; Ana Gonzalez-Pinto; Nuria Cruz; Jose Sanchez-Moreno; Eduard Vieta
Journal:  J Clin Psychiatry       Date:  2009-06-02       Impact factor: 4.384

7.  Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication.

Authors:  Kathleen R Merikangas; Hagop S Akiskal; Jules Angst; Paul E Greenberg; Robert M A Hirschfeld; Maria Petukhova; Ronald C Kessler
Journal:  Arch Gen Psychiatry       Date:  2007-05

8.  Efficacy and safety of lamotrigine as add-on treatment to lithium in bipolar depression: a multicenter, double-blind, placebo-controlled trial.

Authors:  Marc L M van der Loos; Paul G H Mulder; Erwin G Th M Hartong; Marc B J Blom; Anton C Vergouwen; Herman J U E M de Keyzer; Peter J H Notten; Marijke L Luteijn; Manuela A Timmermans; Eduard Vieta; Willem A Nolen
Journal:  J Clin Psychiatry       Date:  2008-12-30       Impact factor: 4.384

9.  Evidence-based guidelines for treating bipolar disorder: Revised third edition recommendations from the British Association for Psychopharmacology.

Authors:  G M Goodwin; P M Haddad; I N Ferrier; J K Aronson; Trh Barnes; A Cipriani; D R Coghill; S Fazel; J R Geddes; H Grunze; E A Holmes; O Howes; S Hudson; N Hunt; I Jones; I C Macmillan; H McAllister-Williams; D R Miklowitz; R Morriss; M Munafò; C Paton; B J Saharkian; Kea Saunders; Jma Sinclair; D Taylor; E Vieta; A H Young
Journal:  J Psychopharmacol       Date:  2016-03-15       Impact factor: 4.153

Review 10.  The New News about Lithium: An Underutilized Treatment in the United States.

Authors:  Robert M Post
Journal:  Neuropsychopharmacology       Date:  2017-10-04       Impact factor: 7.853
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.